Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities

Christopher M Parry; Isabela Ribeiro; Kamini Walia; Priscilla Rupali; Stephen Baker; Buddha Basnyat

doi:10.1136/bmj.k5322

Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities

BMJ. 2019 Jan 22:364:k5322. doi: 10.1136/bmj.k5322.

Authors

Christopher M Parry^{1

2}, Isabela Ribeiro³, Kamini Walia⁴, Priscilla Rupali⁵, Stephen Baker^{6

7

8}, Buddha Basnyat^{7

9}

Affiliations

¹ Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK christopher.parry@lstmed.ac.uk.
² School of Tropical Medicine and Global Health, Nagasaki University, Japan.
³ Dynamic Portfolio Unit, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
⁴ Department of Medical Microbiology, Institute of Medical Education and Research, Chandigarh, India.
⁵ Department of Medicine, Christian Medical College, Vellore, India.
⁶ Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
⁷ Centre for Tropical Medicine and Global Health, Oxford University, Oxford, UK.
⁸ Department of Medicine, University of Cambridge, Cambridge, UK.
⁹ Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.

Abstract

Investments in newer diagnostics and antimicrobial treatments are critical to improve management of enteric fever in South Asia, say Christopher Parry and colleagues

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Multiple, Bacterial*
Humans
Needs Assessment
Typhoid Fever / diagnosis*
Typhoid Fever / drug therapy*
Typhoid Fever / prevention & control
Typhoid-Paratyphoid Vaccines

Substances

Anti-Bacterial Agents
Typhoid-Paratyphoid Vaccines